Piper Sandler lowers DexCom stock price target to $75 on growth concerns
NegativeFinancial Markets

Piper Sandler has lowered its price target for DexCom's stock to $75 due to concerns about the company's growth prospects. This adjustment reflects the analysts' worries about DexCom's ability to maintain its momentum in a competitive market. Investors should pay attention to this change as it may impact DexCom's stock performance and overall market perception.
— Curated by the World Pulse Now AI Editorial System










